CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Purple Biotech Ltd   (PPBT)
Other Ticker:  
 


Purple Biotech Ltd's ROI from the fourth quarter of 2022 to the fourth quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Purple Biotech Ltd's ROI in the fourth quarter of 2022?
Purple Biotech Ltd achieved a return on average invested assets (ROI) of 46.2 % in its fourth quarter of 2022, this is above PPBT's average return on investment of 40.43%.
Purple Biotech Ltd invested over the 12 months ending in its fourth quarter of 2022 $47 million

ROI has improved compared to 35.65% in the third quarter of 2022, due to net income growth.

Within the Healthcare sector 12 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2022 from 0 to 72.

Definition and Formula of Return on Investment


Return On Investment (Dec 31 2022)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Investment Change -28.58 % -28.58 % -28.58 % -28.58 % -
Y / Y Net Income Change 17.83 % - - - -34.22 %
Investment (TTM) in Millions 47 47 47 47 66
Return On Investment (TTM) 46.2 % 35.65 % 32.67 % 30.16 % 28 %
PPBT's Overall Ranking # 72 # 0 # 0 # 0 # 417
Seq. Investment Change 0 % 0 % 0 % -28.58 % 0 %
Seq. Net Income Change - - - - -
Net Income (TTM) in Millions 22 18 18 18 18

PPBT Company Profile >> Back to PPBT Roi Comparisons >> See Annual PPBT Return On Investment



Return On Investment PPBT's Ranking
Within: No.
Industry # 9
Sector # 13
Overall # 72

Return On Investment Statistics
High Average Low
52.75 %
40.43 %
28 %
(Dec 31 2019)   (Dec 31 2021)





Financial Statements
Purple Biotech Ltd's IV. Quarter Investments $ 47 Millions PPBT's Balance sheet
Purple Biotech Ltd's IV. Quarter Income $ 22 Millions Quarterly PPBT's Income Statement
PPBT's Income by Division See PPBT's Income by Division


PPBT Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 47 66 81 11 11
Y / Y Investment Growth -28.58 % -18.29 % 622.39 % -2.08 % -19.56 %
Net Income in Millions 22 18 28 6 6
Y / Y Net Income Growth 17.83 % -34.22 % 376.4 % 5.82 % -
Annual Return On Investment 46.2 % 28 % 34.79 % 52.75 % 48.81 %


Annual Roi Comment
In the fiscal year 2022 ROI improved to 46.2 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PPBT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for PPBT's Competitors
Roi for Purple Biotech Ltd's Suppliers
Return On Investment for PPBT's Customers

Other Ratios
PPBT's Roa PPBT's Inventory Turnover Ratio PPBT's Growth Rates PPBT's Dividend Statistics
PPBT's Profitability Ratios PPBT's Asset Turnover Ratio PPBT's Dividend Growth
PPBT's Roe PPBT's Valuation Ratios PPBT's Financial Strength Ratios PPBT's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2022, within Healthcare Sector ROI
Molecular Templates Inc   115.34 %
Chimerix inc   111.85 %
Acelrx Pharmaceuticals Inc  100.95 %
Gamida Cell Ltd   84.11 %
Ocuphire Pharma Inc   79.52 %
Intercept Pharmaceuticals inc   65.19 %
Kiniksa Pharmaceuticals Ltd   62.52 %
Denali Therapeutics Inc   61.78 %
Chemomab Therapeutics Ltd   58.06 %
Biomx Inc   57.59 %
Dariohealth Corp   54.89 %
Sensus Healthcare Inc   51.84 %
Shockwave Medical Inc   51.53 %
Molecular Partners Ag  48.10 %
Check cap Ltd   46.25 %
Purple Biotech Ltd   46.20 %
Assertio Holdings inc   45.86 %
Idexx Laboratories Inc  43.77 %
Vaso Corporation  43.55 %
Moderna Inc   43.00 %
Dynavax Technologies Corporation  41.67 %
Fusion Pharmaceuticals Inc   40.25 %
Scisparc Ltd   40.19 %
Mettler Toledo International Inc  38.95 %
Harmony Biosciences Holdings inc   36.70 %
Medpace Holdings Inc   34.89 %
Zymeworks Inc   34.67 %
Embecta Corp   33.93 %
Avid Bioservices Inc   32.48 %
National Research Corporation  31.87 %

Date modified: 2023-03-23T13:12:32+00:00



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071